Full video transcriptClick to expand
Auto-generated transcript of @michaelcesaroni's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Because I was on TRT.
- 0:01When I did get off of it, I did have not crazy side effects,
- 0:04but it would definitely I could feel like I wasn't the same.
- 0:07I lost the energy that I had.
- 0:09I did have a few weeks of like kind of just being down
- 0:11and out, but anything that you're a slave to
- 0:13is just not good.
- 0:14I wouldn't suggest anybody getting involved
- 0:16in anything that you need to continuously do over time.
- 0:19It's just not worth it,
- 0:19because you're gonna end up a,
- 0:20spending a ton of money on it.
- 0:22B, you're gonna give up your health,
- 0:23sacrifice your, you know, all that shit.
- 0:25So you just better off not using it.
- 0:27There's so many different ways
- 0:27that you can raise your testosterone naturally
- 0:29and get a good physique naturally.
TRT and HGH: who actually needs hormone therapy?
Quick answer
The creator describes post-TRT cessation symptoms consistent with HPG axis suppression, including fatigue and low mood lasting several weeks, which are documented consequences of stopping exogenous testosterone without medical supervision. His core warning applies most directly to men using TRT without confirmed hypogonadism, where the risk-benefit calculation is genuinely unfavorable. Men with clinically diagnosed low testosterone have a different risk profile and should not interpret this video as guidance to avoid or discontinue treatment.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT and HGH: who actually needs hormone therapy?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT and HGH: who actually needs hormone therapy? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT and HGH: who actually needs hormone therapy?" from Michael Cesaroni. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes post-TRT cessation symptoms consistent with HPG axis suppression, including fatigue and low mood lasting several weeks, which are documented consequences of stopping exogenous testosterone without medical supervision.
The reason this review is not generic is the source wording and the canonical claim label "trt if you don t need it don t start it test testosterone trt hg." In this clip, the useful excerpt is: "Because I was on TRT." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator describes post-TRT cessation symptoms consistent with HPG axis suppression, including fatigue and low mood lasting several weeks, which are documented consequences of stopping exogenous testosterone without medical supervision.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes post-TRT cessation symptoms consistent with HPG axis suppression, including fatigue and low mood lasting several weeks, which are documented consequences of stopping exogenous testosterone without medical supervision. His core warning applies most directly to men using TRT without confirmed hypogonadism, where the risk-benefit calculation is genuinely unfavorable. Men with clinically diagnosed low testosterone have a different risk profile and should not interpret this video as guidance to avoid or discontinue treatment.
- The AUA 2022 guidelines recommend TRT only for men with confirmed symptomatic hypogonadism, defined as total testosterone below 300 ng/dL on two separate morning measurements with clinical symptoms present.
- The 2023 TRAVERSE trial (Lincoff et al., NEJM, n=5,246) found testosterone therapy did not significantly increase major cardiovascular events in men with hypogonadism and elevated cardiovascular risk.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The AUA 2022 guidelines recommend TRT only for men with confirmed symptomatic hypogonadism, defined as total testosterone below 300 ng/dL on two separate morning measurements with clinical symptoms present.
- The 2023 TRAVERSE trial (Lincoff et al., NEJM, n=5,246) found testosterone therapy did not significantly increase major cardiovascular events in men with hypogonadism and elevated cardiovascular risk.
- Ramasamy et al. (2015, Journal of Urology) found that endogenous testosterone recovery after TRT cessation varies widely, with some men experiencing suppression lasting six months or more, supporting the creator's withdrawal experience.
- Lifestyle interventions, including resistance training and sleep optimization, can raise testosterone by roughly 15-20% in healthy men per Zitzmann (2011, Nature Reviews Urology), but are unlikely to correct clinical hypogonadism.
- Starting TRT without a clinical indication is the real problem the creator is describing. His caption framing, 'if you don't need it, don't start it,' is more accurate than his broader claim that TRT harms health.
- Men considering stopping TRT should work with a physician. Protocols including selective estrogen receptor modulators like clomiphene have been studied to assist HPG axis recovery, though off-label use should be evaluated individually.
- Cost is a legitimate practical consideration, but it does not constitute a health risk. Framing financial burden and health risk as equivalent concerns, as the creator does, conflates two distinct issues.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @michaelcesaroni actually say?
He's saying TRT left him dependent, cost him money, and ultimately wasn't worth it. After stopping, he felt depleted for a few weeks — "not crazy side effects" but enough to notice. His core argument: anything you "need to continuously do over time" isn't worth starting, and natural testosterone optimization is a better path.
To his credit, he's not selling anything here. This reads as a genuine personal reflection on his own experience, not a supplement pitch. That matters when evaluating the intent. But intent and accuracy are different things, and several of his broader conclusions deserve a closer look.
Does the science back this up?
Partially, but the picture is more complicated than he's letting on. The withdrawal symptoms he describes — low energy, feeling "down and out" — are real and documented. But the framing that TRT is universally a bad deal ignores a substantial body of evidence showing it's clinically appropriate for men with confirmed hypogonadism.
The 2023 TRAVERSE trial (Lincoff et al., New England Journal of Medicine) followed over 5,000 men on testosterone therapy and found no significant increase in cardiovascular events compared to placebo in men with hypogonadism and elevated cardiovascular risk. Quality of life, sexual function, and mood outcomes improved. That's not a ringing endorsement for recreational use, but it's a far cry from "you're gonna give up your health."
On the withdrawal side, he's on firmer ground. When exogenous testosterone is stopped, the hypothalamic-pituitary-gonadal (HPG) axis suppression doesn't reverse immediately. A 2015 study by Ramasamy et al. in the Journal of Urology found that recovery of natural testosterone production after TRT cessation can take months, and in some cases longer. The weeks of fatigue and low mood he experienced are consistent with temporary secondary hypogonadism during that recovery window.
What did they get wrong (or right)?
He got the withdrawal experience right. The HPG axis suppression after exogenous testosterone is real, well-documented, and genuinely disruptive for some men. The symptom pattern he described aligns with what the research shows.
Where he goes sideways is the blanket claim that TRT means you'll "sacrifice your health." That's not supported by current evidence when TRT is used appropriately, under medical supervision, for men with clinically low testosterone. The TRAVERSE trial specifically addressed the cardiovascular safety concern that has historically been the biggest knock against TRT — and largely cleared it for the studied population.
His claim that "there's so many different ways to raise your testosterone naturally" is worth scrutinizing too. Yes, sleep, resistance training, weight management, and stress reduction have documented effects on testosterone levels. A 2011 meta-analysis by Zitzmann (Nature Reviews Urology) confirmed lifestyle interventions can modestly improve testosterone. But if a man's baseline is genuinely suppressed due to primary or secondary hypogonadism, lifestyle changes are unlikely to be sufficient. Conflating "I optimized my lifestyle and felt better" with "clinical hypogonadism can be fixed naturally" is a meaningful error.
What should you actually know?
TRT is not one-size-fits-all. If your testosterone is clinically low — confirmed by repeat blood testing, with symptoms — TRT has a legitimate evidence base behind it. If you're starting it to chase performance or aesthetics with normal baseline levels, that's a different risk-benefit calculation, and his skepticism there is more warranted.
The dependency concern is real but often mischaracterized. Men with hypogonadism are, by definition, already dealing with a hormone deficiency. Treating a deficiency long-term isn't the same as creating a harmful dependency. The more accurate framing is: starting TRT when you don't need it creates an artificial deficiency that's then hard to reverse. His caption actually says this directly — "if you don't need it, don't start it" — and that part is solid advice.
Before starting or stopping TRT, talk to a physician who can order the right labs (total testosterone, free testosterone, LH, FSH at minimum) and assess whether your symptoms have a hormonal cause. Stopping without a medically supervised protocol can extend and worsen the recovery period he described.
Bottom line
His personal experience is valid. His withdrawal symptoms are scientifically plausible. But the leap from "I didn't need it and regretted starting" to "TRT isn't worth it and will harm your health" oversimplifies a treatment with genuine clinical utility for the right patients. The nuance he's missing: the problem wasn't TRT, it was using TRT without a clinical indication.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Michael Cesaroni · TikTok creator
7.2K views on this video
If you don’t need it, don’t start it #test #testosterone #trt #hgh #fitness #health
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the aua 2022 guidelines recommend trt only for men with?
The AUA 2022 guidelines recommend TRT only for men with confirmed symptomatic hypogonadism, defined as total testosterone below 300 ng/dL on two separate morning measurements with clinical symptoms present.
What does the video say about the 2023 traverse trial (lincoff et al., nejm, n=5,246) found?
The 2023 TRAVERSE trial (Lincoff et al., NEJM, n=5,246) found testosterone therapy did not significantly increase major cardiovascular events in men with hypogonadism and elevated cardiovascular risk.
What does the video say about ramasamy et al. (2015, journal of urology) found?
Ramasamy et al. (2015, Journal of Urology) found that endogenous testosterone recovery after TRT cessation varies widely, with some men experiencing suppression lasting six months or more, supporting the creator's withdrawal experience.
What does the video say about lifestyle interventions, including resistance training?
Lifestyle interventions, including resistance training and sleep optimization, can raise testosterone by roughly 15-20% in healthy men per Zitzmann (2011, Nature Reviews Urology), but are unlikely to correct clinical hypogonadism.
What does the video say about starting trt without a clinical indication?
Starting TRT without a clinical indication is the real problem the creator is describing. His caption framing, 'if you don't need it, don't start it,' is more accurate than his broader claim that TRT harms health.
What does the video say about men considering stopping trt should work with a physician. protocols?
Men considering stopping TRT should work with a physician. Protocols including selective estrogen receptor modulators like clomiphene have been studied to assist HPG axis recovery, though off-label use should be evaluated individually.
Not medical advice. This video was made by Michael Cesaroni, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.